NLRP3 and cryopyrin-associated periodic syndrome: The differences in clinical severity between mosaic and germline CAPS patients can be due to several factors, including the type of amino acid exchange, its location in the cryopyrin protein, the functional consequence of the mutation, as well as the level (percentage of cells) and tissue distribution of the mosaicism (7, 9).